NIH Director Jay Bhattacharya reveals that millions in mRNA research contracts were canceled due to public distrust. He argues that without credibility, mRNA technology can't serve its health mission.
In a surprising move, the US Department of Health has canceled contracts worth $500 million related to mRNA vaccine research, sparking concerns about future pandemic preparedness and the direction of vaccine technology.
The NIH's Jay Bhattacharya argues that public distrust led to the cancellation of mRNA vaccine contracts. This statement contrasts with Health Secretary Kennedy's claims about vaccine safety and efficacy.
In a surprising move, U.S. health officials have canceled $500 million in mRNA vaccine research, citing studies that question their safety and effectiveness. Critics warn this decision undermines vital public health advancements made during the pandemic.
Covid-19 infections are surging in several western US states, with wastewater data indicating a rise in activity. Experts caution about the implications of a new variant and recent vaccine contract terminations.
